VMP 35899111000001106

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Alteplase 20mg powder and solvent for solution for injection vials
BNF code 0210020V0AAABAB
Virtual Therapeutic Moiety Alteplase
Date identifier became valid 17 Oct 2018
Previous product identifier 319840006
Abbreviated name Alteplase 20mg inj vials
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 10 Jun 2004
Previous name Alteplase 20mg intravenous infusion vials and diluent
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units vial
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Alteplase
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Dose Form
Formulation Powder and solvent for solution for injection
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Actilyse 20mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd)
Virtual Medicinal Product Packs
Alteplase 20mg powder and solvent for solution for injection vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_6.4.0_20200629000001, imported on 30th June 2020 at 05:07:36.